1. Home
  2. NEXA vs COLL Comparison

NEXA vs COLL Comparison

Compare NEXA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEXA
  • COLL
  • Stock Information
  • Founded
  • NEXA 1956
  • COLL 2002
  • Country
  • NEXA Luxembourg
  • COLL United States
  • Employees
  • NEXA N/A
  • COLL N/A
  • Industry
  • NEXA Metal Mining
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEXA Basic Materials
  • COLL Health Care
  • Exchange
  • NEXA Nasdaq
  • COLL Nasdaq
  • Market Cap
  • NEXA 617.2M
  • COLL 958.8M
  • IPO Year
  • NEXA 2017
  • COLL 2015
  • Fundamental
  • Price
  • NEXA $5.01
  • COLL $32.52
  • Analyst Decision
  • NEXA Sell
  • COLL Strong Buy
  • Analyst Count
  • NEXA 2
  • COLL 4
  • Target Price
  • NEXA $5.75
  • COLL $43.75
  • AVG Volume (30 Days)
  • NEXA 38.8K
  • COLL 304.4K
  • Earning Date
  • NEXA 07-31-2025
  • COLL 08-07-2025
  • Dividend Yield
  • NEXA 2.02%
  • COLL N/A
  • EPS Growth
  • NEXA N/A
  • COLL N/A
  • EPS
  • NEXA N/A
  • COLL 1.25
  • Revenue
  • NEXA $2,813,814,000.00
  • COLL $664,283,000.00
  • Revenue This Year
  • NEXA N/A
  • COLL $20.04
  • Revenue Next Year
  • NEXA $2.53
  • COLL $3.98
  • P/E Ratio
  • NEXA N/A
  • COLL $25.91
  • Revenue Growth
  • NEXA 13.20
  • COLL 17.17
  • 52 Week Low
  • NEXA $4.44
  • COLL $23.23
  • 52 Week High
  • NEXA $9.61
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • NEXA 51.98
  • COLL 69.85
  • Support Level
  • NEXA $4.87
  • COLL $30.60
  • Resistance Level
  • NEXA $5.06
  • COLL $33.22
  • Average True Range (ATR)
  • NEXA 0.17
  • COLL 0.85
  • MACD
  • NEXA 0.03
  • COLL 0.27
  • Stochastic Oscillator
  • NEXA 90.51
  • COLL 82.32

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: